top of page

Exciting Partnership Announcement!

franziskaloewandow

Crearene and Renephro agree to collaborate on Innovative Treatment & Machine Combinations for the Global Dialysis Market 


Crearene AG, based in Frauenfeld, Switzerland, patent holder for innovative treatments in dialysis using creatine compounds and kits, who recently successfully completed a clinical study, and Renephro, based in Bielefeld, Germany, recent winner of an EXIST grant of the German ministry of economy and climate protection (BMWK), developing a patient-individualized dialysis pump, have agreed to collaborate on innovative, individualized treatment technologies bringing enhanced dialysis solutions to the global market. 


Dr. Frank Heideloff (CEO, Crearene AG) explains: “Today, there are more than 3.5 million dialysis patients globally who rely on regular hemodialysis treatment. There has been little to no innovation over the years regarding treatments improving the quality of life of dialysis patients. Our recently concluded clinical study has demonstrated that the chronic creatine depletion of dialysis patients can be overcome by adding creatine in the dialysis process. The patented know-how of Crearene, result of many years of research on the use of creatine, can serve as a catalyst here. We expect our technology in combination with the manufacturing innovation brought forward by Renephro to be an excellent base for this revolutionizing dialysis treatment.” 


Marvin Lohse (CTO and co-founder of Renephro) adds: “The recent improvements in dialysis machines have largely focused on controls and stability in terms of reproduceable, stable technical processes. But patient conditions vary significantly among chronic kidney disease patients and differ over time. Hence our innovative device aims to introduce patient-individualized treatment patterns into the dialysis market, lowering physical stress on e.g. the cardio-vascular system of dialysis patients plus reducing total system cost.” 



25 Ansichten0 Kommentare

Aktuelle Beiträge

Alle ansehen

Comments


bottom of page